FundedIQ

Recently Funded Biotechnology Startups in the United States

Updated Sep 2026

Funded Biotechnology startups in the United States (US) number 2,510 in FundedIQ, tracked with their funding rounds, amounts, investors, industries, locations and company details. This page provides an overview of the Biotechnology startup funding landscape in the United States, along with the 100 most recently funded Biotechnology startups in the United States.

The median disclosed round is $11M, with the middle half of rounds falling between $3.0M and $53M. Cambridge and San Diego hold the deepest concentrations of these companies. Biotechnology startups in the United States closed 1,370 funding rounds over the last 24 months, 709 of them in the last 12 months, and raised $67B in disclosed capital.

Biotechnology funding clusters heavily around Cambridge and San Diego. While San Francisco and New York provide additional focal points, the concentration in Massachusetts and California dominates. Sourcing deals involves focusing on these specific urban centers. Fidelity and the National Science Foundation back these ventures across various stages, making a few cities the primary gateway for this sector.

Biotechnology funded startup statistics in the United States

Funded Biotechnology startups in the United States
2,510
tracked in the database
Funding rounds, last 12 months
709
1,370 over 24 months
Disclosed capital raised, 24 months
$67B
1,205 of 1,370 rounds disclosed an amount
Median round size
$11M
middle half $3.0M to $53M

Most recent funding round on record: Aug 2026. Investors appearing most often across Biotechnology in the United States funding rounds: Fidelity, National Science Foundation, Cormorant Asset Management, Eli Lilly, Foresite Capital.

100 most recently funded Biotechnology startups in the United States

100 of 2,510

Ordered by the date of the latest funding round. Each row gives the company, its location and industry, what it does, the stage and date of that round, and the disclosed amount.

N
Pittsburgh, United States · Biotechnology
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
Convertible Note ·
$6.8M
X
San Diego, United States · Biotechnology
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Series Unknown ·
$3.0M
N
Milwaukee, United States · Biotechnology
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Seed ·
$3.1M
A
Newton, United States · Biotechnology
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Series D ·
$66M
G
Gaithersburg, United States · Biotechnology
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Series B ·
$93M
B
Northbrook, United States · Biotechnology
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
Series C ·
$110M
I
Seattle, United States · Biotechnology
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Series B ·
$77M
P
Salt Lake City, United States · Biotechnology
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Series A ·
$6.3M
E
South San Francisco, United States · Biotechnology
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Series C ·
$90M
O
Lexington, United States · Biotechnology
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
Series A ·
$7.0M
A
Laguna Hills, United States · Biotechnology
Aureka Biotechnologies is a pioneering biotech firm dedicated to democratizing the pharmaceutical sector in…
Series B ·
$100M
I
Minnesota City, United States · Biotechnology
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Convertible Note ·
$1.3M
R
Needham, United States · Biotechnology
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Series A ·
$10M
L
Cambridge, United States · Biotechnology
LifeMine Therapeutics combines genomics with AI and synthetic biology to discover and develop a pipeline of…
Series E ·
$188M
M
Cambridge, United States · Biotechnology
Metaphore Biotechnologies use biomimicry and machine learning to unveil the revolutionary medicinal potential…
Series Unknown ·
Undisclosed
B
Richmond, United States · Biotechnology
BRAINBox provides objective evidence of injury and prediction of patient recovery. BRAINBox Solutions'…
Series Unknown ·
Undisclosed
C
Scottsdale, United States · Biotechnology
CND Life Sciences is committed to supporting patients with neurodegenerative diseases, offering the Syn-One…
Private Equity ·
Undisclosed
D
Boston, United States · Biotechnology
Dash Bio is a cutting-edge platform that employs AI, robotics, and fully integrated software to revolutionize…
Series A ·
$30M
G
Ann Arbor, United States · Biotechnology
Genomenon develops software tools to rapidly and autonomously prioritize data points for decision-making. It…
Series Unknown ·
$6.0M
A
San Francisco, United States · Biotechnology
Adjuvia Therapeutics is a clinical-stage biopharmaceutical company.
Seed ·
$8.0M
C
Burlington, United States · Biotechnology
CoreMap exists to improve patient outcomes by delivering advanced diagnostic technology to…
Series C ·
$37M
S
Baltimore, United States · Biotechnology
Sonavex, Inc. is a Baltimore-based medical device company originally spun out of Johns Hopkins focused on…
Series Unknown ·
$3.1M
A
Carlsbad, United States · Biotechnology
ALZpath is a biotech organization that offers innovative diagnostic options for Alzheimer's disease.
Series Unknown ·
$8.4M
R
New York, United States · Biotechnology
Reme-D is a cutting-edge technology company that has patented technology, which is revolutionizing healthcare…
Seed ·
$1.4M
T
San Francisco, United States · Biotechnology
Trellis Bioscience develops a technology platform for cellular informatics. The company's technology has…
Series C ·
$9.0M
S
Sarcomatrix
San Francisco, United States · Biotechnology
Sarcomatrix, Inc. is pioneering novel therapeutics that leverage our understanding of muscle biology and…
Seed ·
Undisclosed
L
Providence, United States · Biotechnology
Lyora Therapeutics develops genetic medicines for inherited retinal diseases that currently have no treatment.
Pre-Seed ·
$2.5M
W
St Louis, United States · Biotechnology
Wugen is a developer of a novel CAR-T therapy platform intended for T-Cell Malignancies.The company's…
Series C ·
$35M
F
Philadelphia, United States · Biotechnology
Fore Biotherapeutics is a precision oncology company specializing in cancer therapies guided by functional…
Series D ·
$67M
E
Santa Rosa, United States · Biotechnology
ETI have fostered a protected, novel clinical gadget that eliminates galectin-3 from human blood. The gadget…
Equity Crowdfunding ·
$40k
K
Honolulu, United States · Biotechnology
Kuehnle Agrosystems, Inc. specializes in biotech research and development of plant-based systems used for…
Series B ·
Undisclosed
A
Seattle, United States · Biotechnology
Aptevo Therapeutics is a biotech company based in Seattle that focuses on developing new treatments for…
Series Unknown ·
$1.5M
B
Boston, United States · Biotechnology
Beeline Medicines is a biotechnology company that identifies and provides precise treatments to autoimmune…
Series A ·
$126M
C
Ponte Vedra Beach, United States · Biotechnology
Cadrenal Therapeutics is a late-stage biopharmaceutical company developing tecarfarin, an oral therapeutic…
Series Unknown ·
$3.0M
F
Cambridge, United States · Biotechnology
Flare Therapeutics is a biotech firm that is venturing into a new therapeutic domain by taking a unique…
Series C ·
$85M
P
Boston, United States · Biotechnology
Pyxis Oncology is a developer of antibody therapeutics intended to promote the body's immune response to…
Series Unknown ·
$50M
T
Morgan Hill, United States · Biotechnology
Tenon Medical, a biotech firm specializing in enhancing surgical solutions for the SI joint, was established…
Series Unknown ·
$4.2M
4
Emeryville, United States · Biotechnology
4D Molecular Therapeutics is a biotechnology company.The Company designs, develops, and commercializes…
Series Unknown ·
$200M
A
Aurora, United States · Biotechnology
Andon Bio is a biotechnology company that measures genetic parameters such as tRNAs predict and analyze…
Seed ·
$250k
N
Fort Lee, United States · Biotechnology
Nuvectis Pharma is a biopharmaceutical company focused on creating new targeted treatments for cancer. The…
Series Unknown ·
$100M
S
Holland, United States · Biotechnology
Shoulder Innovations is a medical device company that has developed inset glenoid fixation technology,…
Series Unknown ·
$45M
D
Cambridge, United States · Biotechnology
Decoy Therapeutics is a preclinical stage biotech company building a pandemic preparedness drug development…
Series Unknown ·
$3.5M
S
San Francisco, United States · Biotechnology
Siren Biotechnology combines AAV gene therapy and cytokine immunotherapy into a new method for treating…
Series Unknown ·
$8.0M
A
San Francisco, United States · Biotechnology
ALX Oncology is a biotech company focused on creating groundbreaking cancer immunotherapy treatments. It…
Series Unknown ·
$10M
E
Monrovia, United States · Biotechnology
eXoZymes focuses on creating enzymes and developing enzyme pathways that can function independently outside…
Series Unknown ·
$2.0M
I
Albuquerque, United States · Biotechnology
Picture a future where cancer can be identified at its early stages, enabling treatments that are…
Series Unknown ·
$2.6M
L
San Diego, United States · Biotechnology
Lycia Therapeutics is a biotechnology company that focuses on developing technology that utilizes…
Series D ·
$75M
N
Columbus, United States · Biotechnology
NeuroLife is a neurotechnology company bringing more than a decade of research and development into a focused…
Seed ·
$2.9M
N
New York, United States · Biotechnology
Series Unknown ·
$250M
O
Oakland, United States · Biotechnology
Oblenio Bio is a biotechnology company that develops T-cell engager therapeutic candidates for autoimmune…
Series B ·
$62M
O
Optimeos Life Sciences
Princeton, United States · Biotechnology
Optimeos Life Sciences is a biotechnology company that enables the use of biologics, peptides, and RNA to…
Series Unknown ·
Undisclosed
C
La Jolla, United States · Biotechnology
Series Unknown ·
$49M
S
Salt Lake City, United States · Biotechnology
Sera is a women’s health diagnostics company dedicated to improving the lives of women and babies through…
Series Unknown ·
$10M
T
Dallas, United States · Biotechnology
Taysha Gene Therapies is dedicated to eliminating serious and life-threatening genetic diseases in the…
Series Unknown ·
$200M
A
Boston, United States · Biotechnology
Anodyne Nanotech is a preclinical-stage biotech company that develops differentiated, transdermal forms of…
Series A ·
$13M
A
Marina Del Rey, United States · Biotechnology
Armata Pharmaceuticals is a biotechnology company that is in the process of developing bacteriophage…
Series Unknown ·
$2.5M
A
ARMR Sciences
New York, United States · Biotechnology
ARMR Sciences develops immunotherapy-based biodefense solutions to prevent overdose from fentanyl and…
Series Unknown ·
Undisclosed
D
New York, United States · Biotechnology
Definium Therapeutics provides psychedelic-inspired medicines and therapies for substance abuse disorders and…
Series Unknown ·
$805M
L
San Diego, United States · Biotechnology
Ligand is a biopharmaceutical company focused on developing or acquiring technologies that help…
Series Unknown ·
$625M
M
MannKind
Valencia, United States · Biotechnology
MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, development, and commercialization of…
Series Unknown ·
Undisclosed
N
Boston, United States · Biotechnology
NorthLinks Bio is a clinical-stage biopharmaceutical company developing HEX17, a intranasal antiviral…
Series Unknown ·
$34M
O
San Francisco, United States · Biotechnology
Osanni Bio is a biotechnology company developing therapies aimed at preventing and reversing blindness caused…
Series B ·
$190M
R
Carlsbad, United States · Biotechnology
Rapalogix Health is a biotechnology company focused on developing longevity-based solutions for skin health…
Series A ·
$20M
S
Sangamo Therapeutics
Richmond, United States · Biotechnology
Sangamo Therapeutics is a clinical-stage biotechnology company that translates ground-breaking science into…
Series Unknown ·
Undisclosed
T
Cambridge, United States · Biotechnology
Seed ·
$14M
X
Gainesville, United States · Biotechnology
X-tosis is pioneering a novel approach to treat Alzheimer's and Parkinson's diseases by targeting…
Series Unknown ·
$2.7M
D
DropGenie
Boston, United States · Biotechnology
DropGenie is building connected hardware to automate gene editing. They are accelerating the pace of…
Seed ·
Undisclosed
E
Endure Biotherapeutics
San Diego, United States · Biotechnology
Endure Biotherapeutics develops engineered live biotherapeutics for the treatment of genetic and chronic…
Series Unknown ·
Undisclosed
N
South San Francisco, United States · Biotechnology
Nura Bio is a biotechnology company that develops neuroprotective therapies for neurological disorders. Its…
Series B ·
$74M
T
Tolerance Bio
Philadelphia, United States · Biotechnology
Tolerance Bio is a biopharmaceutical company focused on manipulating immune tolerance via the thymus to…
Seed ·
Undisclosed
S
Chicago, United States · Biotechnology
Syntax Bio is a synthetic biology and biotechnology company that develops a CRISPR-based cell programming…
Series A ·
$14M
R
San Diego, United States · Biotechnology
Replicate Bioscience is a clinical-stage biotechnology company developing self-replicating RNA (srRNA)…
Series Unknown ·
$3.0M
C
Skokie, United States · Biotechnology
Cour Pharmaceuticals Development Co Inc operates in the pharmaceutical sector. Cour Pharmaceuticals…
Series B ·
$50M
I
Wilmington, United States · Biotechnology
iQure Pharma is a biotechnology company founded by entrepreneurs and ex-pharmaceutical executives that…
Series Unknown ·
Undisclosed
S
Alameda, United States · Biotechnology
Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR. The…
Series Unknown ·
$25M
B
San Antonio, United States · Biotechnology
BioAffinity Technologies, Inc. has developed CyPath® Lung, a noninvasive test that accurately detects…
Series Unknown ·
$3.2M
D
Cambridge, United States · Biotechnology
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.The company's…
Series Unknown ·
$200M
O
Bronx, United States · Biotechnology
Oligomerix is a biopharmaceutical company founded in 2006 by co-founders Eliot J. Davidowitz and James Moe.…
Series Unknown ·
$1.9M
S
Palo Alto, United States · Biotechnology
Spot BioSystems is a bioengineering firm that specializes in personalized cancer treatments. The company's…
Series Unknown ·
$40M
T
Waltham, United States · Biotechnology
Triveni Bio is a biotech company advancing novel antibody treatments for I&I disorders. Using a…
Series C ·
$65M
V
Seattle, United States · Biotechnology
Vedana Therapeutics is a Seattle biotechnology company developing next-generation antibody therapies for…
Series A ·
$46M
A
Minneapolis, United States · Biotechnology
Adialante develops deployable, clinical-grade MRI systems designed to reduce the cost and footprint of…
Pre-Seed ·
$500k
E
Emmecell
Menlo Park, United States · Biotechnology
Emmecell is a biotechnology company that provides developing cell-based therapies.
Series Unknown ·
Undisclosed
K
San Francisco, United States · Biotechnology
Kopra Bio is a Biotechnology Research firm offering that cure cancer through viral immunotherapy technology.
Seed ·
$9.1M
R
Bedford, United States · Biotechnology
At Rejoni, our team is working on developing solutions that minimize both acute and chronic risks associated…
Series Unknown ·
$25M
S
Boston, United States · Biotechnology
Sera Medicines is an operator of biologics accelerator developing and launching next-generation protein…
Series Unknown ·
$38M
C
Vienna, United States · Biotechnology
CEL-SCI Corporation is a biotechnology company. CEL-SCI is involved in the research and development of…
Series Unknown ·
$2.5M
Z
Woburn, United States · Biotechnology
Zumutor is a biotechnology company focused on developing immuno-oncology therapies that harness the body's…
Series B ·
$7.3M
A
Aton Health
Kansas City, United States · Biotechnology
Aton Health connects biotech study sponsors with a network of highly engaged clinicians and unprecedented…
Series A ·
Undisclosed
A
Seattle, United States · Biotechnology
Atossa Therapeutics is a clinical-stage biopharmaceutical company focusing on breast cancer and other breast…
Series Unknown ·
$4.5M
C
Tempe, United States · Biotechnology
Capstone Holding is a diversified platform of building products businesses focused on distribution, brand…
Series Unknown ·
$20M
P
Houston, United States · Biotechnology
PolyVascular is working on the development of transcatheter pulmonary valves made from medical-grade polymer…
Series Unknown ·
$50k
A
Charlottesville, United States · Biotechnology
Adial Pharmaceuticals is a biopharmaceutical business in the clinical stages that specialises on the creation…
Series Unknown ·
$32M
E
Boulder, United States · Biotechnology
Enliven Therapeutics is a company focused on precision oncology, creating small molecule treatments to extend…
Series Unknown ·
$460M
P
Cambridge, United States · Biotechnology
Parabilis Medicines is a biopharmaceutical company in the clinical stage that focuses on developing…
Series Unknown ·
$75M
X
Chicago, United States · Biotechnology
Xeris is a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop…
Series Unknown ·
Undisclosed
F
Brooklyn, United States · Biotechnology
Fesarius Therapeutics is a biotechnology company that intends to develop and sell modified skin replacement…
Series A ·
$20M
H
Morrisville, United States · Biotechnology
Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally…
Series Unknown ·
$50M
N
Woodland Hills, United States · Biotechnology
NEONC Technologies is an early-stage cancer biotechnology company focused initially on intranasal (delivery…
Series Unknown ·
$5.0M
S
Austin, United States · Biotechnology
Shattuck is a clinical-stage biotechnology company advancing its proprietary Agonist Redirected Checkpoint…
Series Unknown ·
$75M

2,410 more funded startups

2510 startups · 100 visible Unlock with FundedIQ

This page shows the 100 most recent rounds (back to Jun 2026). The full 2,510-company history for this listing opens on a FundedIQ plan.

Company
Location
Round
Amount

Unlock all 2,510 companies in this listing: full funding history, investors, and founders.

Start 14-day free trial →

Where are funded Biotechnology startups located in the United States?

Where funded Biotechnology startups in the United States are based, by the city on the company record.

Funded Biotechnology startups in the United States by state

The states with the most funded startups on record.

Top investors in Biotechnology startups in the United States

The investors named most often across funded Biotechnology startups in the United States.

Investor
Companies backed
Fidelity
3
National Science Foundation
3
Cormorant Asset Management
2
Eli Lilly
2
Foresite Capital
2
National Institutes of Health
2
RA Capital Management
2
Soleus Capital
2

Counts companies in this segment that name the firm as a backer. Investor names entered the pipeline in July 2026, so they cover the companies funded since.

Funding stages of funded Biotechnology startups in the United States

How the last 24 months of funding rounds for funded Biotechnology startups in the United States break down by stage.

Stage
Rounds, last 24 months

A further 967 rounds in this period were announced without a stage label and are not ranked above.

About the FundedIQ Biotechnology startup funding data in the United States

FundedIQ tracks announced startup funding rounds and organises them by company, funding date, stage, amount, industry, location and investor. The dataset is refreshed weekly, and new rounds are normalised and de-duplicated before they are published, so the same round reported twice on different dates is recorded once.

Figures on this page cover the 2,510 funded Biotechnology startups in the United States currently tracked. Round counts, capital totals and the median round are computed over a trailing 24 months. Rounds whose amount was not disclosed (165 of 1,370 in that period) are counted as rounds but excluded from capital totals and from the median. The most recent round on record for funded Biotechnology startups in the United States is dated Aug 2026.

The table above shows the 100 most recently funded companies. Full funding histories, investor lists and founder contacts across the whole dataset open on a FundedIQ plan.

Frequently asked questions

How many funded Biotechnology startups are there in the United States?

FundedIQ tracks 2,510 funded Biotechnology startups in the United States. This page lists the 100 most recently funded of them, ordered by the date of their latest round, and the full set is available on a FundedIQ plan.

How much funding have Biotechnology startups in the United States raised?

Biotechnology startups in the United States tracked by FundedIQ have raised $67B in disclosed capital across 1,370 funding rounds over the last 24 months, including 709 rounds in the last 12 months. 1,205 of those 1,370 rounds disclosed an amount; undisclosed rounds are excluded from the capital total.

Which cities have the most funded Biotechnology startups in the United States?

Cambridge leads with 186 companies, then San Diego (151), San Francisco (150) and New York (126).

Which investors back the most Biotechnology startups in the United States?

Fidelity, National Science Foundation, Cormorant Asset Management, Eli Lilly and Foresite Capital appear most often across funded Biotechnology startups in the United States in the FundedIQ dataset. The count is the number of tracked companies naming each firm as a backer, so it reflects the companies on record rather than every deal a firm has ever done.

What is a typical funding round size for Biotechnology startups in the United States?

The median disclosed round over the last 24 months is $11M, and the middle half of rounds fall between $3.0M and $53M. Round sizes vary widely by stage, so the seed and later-stage bands sit well either side of that figure.

What is the most common funding stage for Biotechnology startups in the United States?

Seed is the most common labelled stage, with 119 rounds in the last 24 months, ahead of Series A (109) and Series B (84). A further 967 rounds were announced without a stage label and are not counted here.

How often is the Biotechnology startup funding data in the United States updated?

The dataset is refreshed weekly. New rounds are normalised and de-duplicated before they are published, and the most recent round currently on record for funded Biotechnology startups in the United States is dated Aug 2026. Counts and totals on this page are recomputed on every refresh.

Related listings

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.